Rhenman & Partners Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.8M | Hold |
|
|||||
|
2024
Q1 | $3.45M | Buy |
|
|||||
|
2023
Q4 | $4.18M | Buy |
|
|||||
|
2023
Q3 | $4.15M | Buy |
|
|||||
|
2023
Q2 | $3.11M | Sell |
|
|||||
|
2023
Q1 | $7.16M | Sell |
|
|||||
|
2022
Q4 | $8.09M | Buy |
|
|||||
|
2022
Q3 | $8.66M | Sell |
|
|||||
|
2022
Q2 | $6.22M | Buy |
|
|||||
|
2022
Q1 | $3.87M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $8.91M | Buy |
|
|||||
|
2021
Q2 | $8M | Buy |
|
|||||
|
2021
Q1 | $6.15M | Hold |
|
|||||
|
2020
Q4 | $6.24M | Hold |
|
|||||
|
2020
Q3 | $5.53M | Hold |
|
|||||
|
2020
Q2 | $5.37M | Hold |
|
|||||
|
2020
Q1 | $3.26M | Sell |
|
|||||
|
2019
Q4 | $4.06M | Buy |
|
|||||
|
2019
Q3 | $2.26M | Sell |
|
|||||
|
2019
Q2 | $2.51M | Hold |
|
|||||
|
2019
Q1 | $3.04M | Hold |
|
|||||
|
2018
Q4 | $3.89M | Sell |
|
|||||
|
2018
Q3 | $5.05M | Hold |
|
|||||
|
2018
Q2 | $5.58M | Hold |
|
|||||
|
2018
Q1 | $6.26M | Buy |
|
|||||
|
2017
Q4 | $6.53M | Sell |
|
|||||
|
2017
Q3 | $6.79M | Buy |
|
|||||
|
2017
Q2 | $5.81M | Buy |
|
|||||
|
2017
Q1 | $4.37M | Hold |
|
|||||
|
2016
Q4 | $4.35M | Hold |
|
|||||
|
2016
Q3 | $3.4M | Sell |
|
|||||
|
2016
Q2 | $2.99M | Buy |
|
|||||
|
2016
Q1 | $2.97M | Sell |
|
|||||
|
2015
Q4 | $5.91M | Buy |
|
|||||
|
2015
Q3 | $4.4M | Sell |
|
|||||
|
2015
Q2 | $5.5M | Sell |
|
|||||
|
2015
Q1 | $4.89M | Buy |
|
|||||
|
2014
Q4 | $2.14M | Buy |
|
|||||
|
2014
Q3 | $2.04M | Buy |
|
|||||
|
2014
Q2 | $2.79M | Buy |
|
|||||
|
2014
Q1 | $1.55M | Buy |
|